Apr 29, 2019 - Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does AbbVie (ABBV) have what it takes? Let's find out.
Apr 29, 2019 - BMO Capital Markets issues rating change for ABBV
Apr 25, 2019 - AbbVie Inc. (NYSE:ABBV) Q1 2019 Earnings Conference Call April 25, 2019, 09:00 AM ET Company Participants Elizabeth Shea - VP, IR Rick Gonzalez - Chairman and CEO Michael Severino - Vice Chairman and
Apr 25, 2019 - ABBV earnings call for the period ending March 31, 2019.
Apr 24, 2019 - While Pfizer's (PFE) key drugs like Ibrance and Xeljanz are likely to drive Q1 sales, genericization of key drugs and weak sales in the EH segment will hurt.
Apr 24, 2019 - They were once some of the hottest stocks on the Street. Are they returning to greatness?
Apr 24, 2019 - AbbVie (ABBV) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Apr 22, 2019 - Strong growth of Imbruvica and Mavyret are expected to drive AbbVie (ABBV) first-quarter sales. Declining ex-U.S. Humira sales are likely to be an overhang on the top line.
Apr 18, 2019 - Let's have a look at some of the highlights of J&J's (JNJ) first-quarter 2019 results.
Apr 16, 2019 - J&J (JNJ) beats estimates for both earnings and sales in the first quarter of 2019 and raises 2019 guidance for operational sales and adjusted operational EPS growth. Shares up in pre-market trading.